AKT1 and renal cell carcinoma: The KEGG results indicated that the target genes were mainly enriched in immune system and cancer pathways, such as renal cell carcinoma, pathways in cancer, transcriptional misregulation in cancer, FOXO, PI3K-AKT, MAPK, and NF-κB signaling pathways (Figure 5A).